Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Ruxolitinib Cream + Phototherapy for Vitiligo
Recruiting1 awardPhase 2
This trial will study whether Ruxolitinib cream, with or without phototherapy, can help treat vitiligo in people for whom the affected area does not exceed 10% of their body.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.